Enovap, Developer Of World’s First Smart Personal Vaporizer, Joins The Blinc Group Incubator
NEW YORK (PRWEB) September 14, 2017 -- Enovap, developer of the world’s first smart personal vaporizer able to automatically and manually control nicotine delivery, joins The Blinc Group incubator. Their mission is to introduce Enovap’s technology to investors and strengthen their presence on the U.S. market.
Enovap is bringing state of the art technology to the fight against tobacco, developing the first nicotine management system, thanks to their patented ‘double-tank technology.’ Enovap’s Hit Control system lets users control the nicotine concentration for each puff, optimizing the throat hit sensation and regulating their daily intake of nicotine, optimally relieving cravings. The company has been awarded with a range of prestigious awards, including the Seal of Excellence of the European Commission and the Ilab prize by the French Minister of Research and Innovation.
Alexandre Scheck, CEO of Enovap, explains “Enovap is aiming for a fast commercial expansion of its vaping product in the U.S. Joining The Blinc Group is the perfect opportunity to introduce our technology to players and investors in the field and accelerate our launch in the US market.”
Marie Harang-Elz, PhD., will also be joining The Blinc Group’s Advisory Board. She received her doctorate in the department of Pharmaceutical Sciences at King’s College, studying pressurized metered dose inhalers for the treatment of lung diseases, and went on to manage several commercial projects for the Vype brand and joined Enovap as a scientific developer.
Harang-Eltz, PhD., adds the engagement is “also the chance for us to share our experience and knowledge on vaping and learn from the ongoing U.S. research on vaping and cannabis. We are looking forward to meeting scientists, key opinion leaders and companies to conduct more effective research in this area to help in the development of better nicotine and cannabis delivery vaping technologies.”
Arnaud Dumas de Rauly, Chief Strategy Officer of The Blinc Group says that “Enovap represents a game-changing technology with regards to harm reduction and its applications are infinite, ranging from traditional vaping all the way to medicinal marijuana delivery as well as traditional drug delivery.”
About Enovap
Founded in 2015, Enovap is a startup developing the first connected personal vaporiser that helps smokers by anticipating and adapting to their nicotine needs. The device addresses both tobacco and nicotine addictions thanks to its unique patented nicotine dosage system.
The patented technology first allows smokers to adjust the nicotine concentrations at the touch of a button to help them transitioning out of cigarette use. Once the user has stopped smoking, the user can actuate the nicotine reduction mode to reduce his/her dependence to nicotine and reduce the risk of relapse into smoking in the long term.
About The Blinc Group
The Blinc Group is a first of its kind adoption and distribution-centric incubator led by a connected group of top vapor and cannabis industry experts. The company creates a fostering environment for the launch, expansion, and funding of vapor and cannabis products.
The Blinc Group’s mission is to build quality brands and products that innovate the face of retailers, dispensaries, head shops, and vape shops across the globe. They are invested in informing and improving public health through driving innovation and fostering rewarding consumer experiences.
The company delivers full cycle support to start-ups and entrepreneurs through tailored branding, marketing, sales and engagement programs rooted in data and proprietary research. The Blinc Group leverages their collective expertise and network to position member companies as thought leaders in their respective industry segment and develop a foundation for scaling through the largest distribution channels in the American, European, and Asian markets.
Ethan Andersen, Nison Consulting, +1 7322076771, [email protected]
Share this article